2.49
Waldencast Plc Aktie (WALD) Neueste Nachrichten
What analysts say about Waldencast plc Equity Warrant stockConsistently outstanding ROI - Autocar Professional
Croma-Pharma GmbH Announces Strategic Milestone as Novaestiq Corp. Joins Waldencast - Infosalus
What analysts say about Waldencast plc stockFree Stock Market Forecast Reports - Autocar Professional
Is Waldencast plc a good long term investmentAccelerated earnings growth - Autocar Professional
Gore Range Capital Announces Sale of Novaestiq Corp. to Waldencast - Great Falls Tribune
Waldencast plc Stock Analysis and ForecastAccelerated wealth building - Autocar Professional
Waldencast to Acquire Novaestiq, US Rights to Saypha Line of Injectable Hyaluronic Acid Gels - MarketScreener
Waldencast Acquires Novaestiq and U.S. Rights to Saypha® - TipRanks
Waldencast acquires Novaestiq to expand Obagi Medical into injectables By Investing.com - Investing.com South Africa
Waldencast Acquires Novaestiq Corp, Expanding Obagi Medical's Injectable Product Portfolio and Market Reach - Nasdaq
Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream - Yahoo.co
Waldencast acquires Novaestiq Corp. and U.S. rights to leading injectable hyaluronic acid gel line, Saypha, under the Obagi Medical brand - MarketScreener
Waldencast Doubles Market Reach to $4.2B Through Major Aesthetics Acquisition and Injectable Product Rights - Stock Titan
Waldencast plc Equity Warrant Stock Analysis and ForecastRapid portfolio appreciation - jammulinksnews.com
Is Waldencast plc Equity Warrant a good long term investmentBreakthrough stock performance - jammulinksnews.com
What drives Waldencast plc Equity Warrant stock priceDouble-digit growth - printweek.in
What drives Waldencast plc stock priceExceptional growth trajectory - jammulinksnews.com
How Waldencast plc stock reacts to Fed policy changesWeekly Double Return List - Newser
Will Waldencast plc Equity Warrant stock split in the near future200 Percent Profit Outlook - beatles.ru
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):